S100B is a biomarker of cerebral injury, neuroinflammation and blood brain barrier permeability4, and S100B was also found to be increased in patients with ACS5; therefore, it is conceivable that the higher the circulating S100B levels, the greater the procoagulant tendency at baseline could be. This evidence concerns the gene S100B and Pfeiffer syndrome.